Cooper Embarks on Ground-Breaking Trial of First, Totally Subcutaneous, Cardioverter-Defibrillator
It is estimated over 650,000 people in the United States currently have implanted cardiac devices (ICD’s) designed for defibrillation. Cooper University Hospital has recently become one of the first U.S. centers to participate in a ground-breaking clinical trial examining the …